IRulya Therapeutics Inc 10-Q for FY2023 Q3
IRulya Therapeutics Inc. (IRLA)
10-Q
2023-11-14
For: 2023-09-30
View Original
Added on
April 05, 2026
About this 10-Q
IRulya Therapeutics Inc filed this 10-Q on November 14, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $5.35M
- compared with a net loss of $7.92M a year earlier
- Diluted EPS
- -$0.15
- compared with -$0.22 a year earlier